To explore the ability of hiNeuroSRANTES‐IL‐15 to enhance the anti‐tumor cytotoxicity of CAR‐T therapy, FLuc+ U87 cells were co‐cultured with increasing amounts of CSPG4‐CAR‐T cells in the presence of NS‐CM or control media for 72 h. This evidence concerns the gene IL15 and neoplasm.